Why It Matters

The Family of Freeda Breuer filed a 2026 quarter three lobbying report disclosing $100,000 in spending on issues related to the Organ Procurement and Transplantation Network (OPTN). The filing puts a private family on record in a federal policy arena where the Health Resources and Services Administration (HRSA) is actively rolling out new OPTN operational requirements. ​

By the Numbers

The third-quarter filing reports $100,000 in lobbying expenditures, signed October 9, through outside firm Stonington Global LLC.

The client's only prior filing is a new client registration from earlier in 2026 reporting $0, with no quarter designation.

Dr. Nick Muzin is the sole lobbyist named on the filing, listed as principal at Stonington Global LLC. His congressional record shows prior service as a senior adviser in the personal offices of Sen. Tim Scott (R-SC) and Sen. Ted Cruz (R-TX) during the 112th through 114th Congresses.

Broader Context

The Securing the U.S. Organ Procurement and Transplantation Network Act became Public Law 118-14 in September 2023, establishing a framework for OPTN contracting and governance reforms.

HRSA announced in July 2026 that a new OPTN policy for living-donor recovery and transplant hospitals would take effect August 17. On September 23, HRSA said new OPTN requirements for donation after circulatory death would take effect November 18.

Two bills in the 119th Congress address OPTN fee authority. H.R. 5259, the Permanent OPTN Fee Authority Act, was introduced by Rep. Jim Costa (D-CA) and referred to the House Energy and Commerce Committee in September 2025.

A Congressional Research Service report on the Organ Procurement and Transplantation Network covers the network's administration, oversight, and policy issues, including the 2023 law that established a framework for network reform. A February 2025 Congressional Research Service report examined OPTN administration, oversight, and policy issues under the 2023 law's reform framework without endorsing a particular position.

The Bottom Line

The third quarter 2026 report from Stonington Global LLC lists $100,000 and is the only quarterly report identified for this client, so there is no earlier quarter to compare it with.

Access the Legis1 platform for comprehensive political news, data, and insights

Spot something wrong? Report an issue with this article